News

News from Partners

Jornal da USP: Skin cancer rises by 1,500% in Brazil over ten years

This content is in Portuguese.

2 de março de 2026

News from Partners

Jornal da USP: Protein May Explain the Aggressive Progression of Pancreatic Cancer

This content is in Portuguese.

27 de fevereiro de 2026

News from Partners

Jornal da USP: Hospital das Clínicas de São Paulo stands out among the world’s 250 best hospitals

This content is in Portuguese.

27 de fevereiro de 2026

News from Partners

Jornal da USP: New skin cancer vaccine reduces the risk of death and tumor recurrence by 49%.

This content is in Portuguese.

25 de fevereiro de 2026

News from Partners

FMUSP: Prof. Dr. Luisa Lina Villa receives the Carolina Bori Science & Women Award

This content is in Portuguese.

19 de fevereiro de 2026

News from Partners

Icesp: Icesp treats the most complex cancer cases in the State of São Paulo: understand the data

This content is in Portuguese.

18 de fevereiro de 2026

News from Partners

Jornal da USP: Brazilian natural product demonstrates anticancer activity and enhances the action of chemotherapeutic agents

This content is in Portuguese.

11 de fevereiro de 2026

C2PO News

FLAB nanoscaffold combines cancer diagnosis and therapy

Theranostic platform combines cisplatin, nanoparticles, and fluorescence to improve treatment delivery and diagnosis.

3 de fevereiro de 2026

C2PO News

CAR-T in resource-limited regions: challenges and perspectives for Brazil

CAR-T cell therapy has been transforming the treatment of hematological neoplasms, but its implementation in countries such as Brazil still faces significant barriers.

3 de fevereiro de 2026

News from Partners

Jornal da USP: USP professors win the 7th Carolina Bori Science & Women Award

This content is in Portuguese.

22 de janeiro de 2026

News from Partners

Jornal da USP: Study investigates the relationship between longevity among Brazilian supercentenarians and genetic admixture

This content is in Portuguese.

12 de janeiro de 2026

News from Partners

Icesp: Get to know the Icesp Recombinant Viral Vectors Core Facility: a differentiated technology offering for research

This content is in Portuguese.

5 de janeiro de 2026